Evidence map›Paper›PMID 35195681›Full record

ReviewThe Journal of experimental medicine2022

The gut-meningeal immune axis: Priming brain defense against the most likely invaders.

Rafael Di Marco Barros, Zachary Fitzpatrick, Menna R Clatworthy

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of experimental medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Rafael Di Marco BarrosMolecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-6484-2317
Zachary FitzpatrickSpark Therapeutics, Philadelphia, PA.
Menna R ClatworthyMolecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3340-9828
University of Cambridge · GBSpark Therapeutics (United States) · US

Funding

Department of Health RP-2017-08-ST2-002Medical Research Council MR/S035842/1Wellcome TrustWellcome Trust 220268/Z/20/Z
6 · The paper itself

Abstract

The gastrointestinal tract contains trillions of microorganisms that exist symbiotically with the host due to a tolerant, regulatory cell-rich intestinal immune system. However, this intimate relationship with the microbiome inevitably comes with risks, with intestinal organisms being the most common cause of bacteremia. The vasculature of the brain-lining meninges contains fenestrated endothelium, conferring vulnerability to invasion by circulating microbes. We propose that this has evolutionarily led to close links between gut and meningeal immunity, to prime the central nervous system defense against the most likely invaders. This paradigm is exemplified by the dural venous sinus IgA defense system, where the antibody repertoire mirrors that of the gut.

Indexed as

AnimalsGastrointestinal MicrobiomeGastrointestinal TractHumansImmunoglobulin AMeningesModels, ImmunologicalPlasma CellsImmunoglobulin A

Identifiers

PMID35195681
PMCPMC8932540
OpenAlexW4213445534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.